Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C5H4N4S |
| Molecular Weight | 152.177 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
S=C1N=CNC2=C1C=NN2
InChI
InChIKey=PYAOPMWCFSVFOT-UHFFFAOYSA-N
InChI=1S/C5H4N4S/c10-5-3-1-8-9-4(3)6-2-7-5/h1-2H,(H2,6,7,8,9,10)
| Molecular Formula | C5H4N4S |
| Molecular Weight | 152.177 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Tisopurine (or Thiopurinol) was used in the treatment of gout. This drug reduces uric acid concentrations by interfering with the early stages of its synthesis, thus avoiding increased blood concentrations of hypoxanthine and xanthine. In addition, it was discovered, that tisopurine caused acute hepatitis.
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL2364183 Sources: https://www.ncbi.nlm.nih.gov/pubmed/8178077 |
|||
Target ID: GO:0070527 Sources: https://www.ncbi.nlm.nih.gov/pubmed/2551060 |
|||
Target ID: CHEMBL367 |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Biochemical characterization of some pyrazolopyrimidine-based inhibitors of xanthine oxidase. | 2006 |
|
| Development of new fungicides against Magnaporthe grisea: synthesis and biological activity of pyrazolo[3,4-d][1,3]thiazine, pyrazolo[1,5-c][1,3,5]thiadiazine, and pyrazolo[3,4-d]pyrimidine derivatives. | 2002-08-14 |
|
| Structure-activity relationships for the binding of ligands to xanthine or guanine phosphoribosyl-transferase from Toxoplasma gondii. | 1995-11-09 |
|
| Antithrombotic effect of thiopurinol. | 1989-06-15 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:21:21 GMT 2025
by
admin
on
Mon Mar 31 18:21:21 GMT 2025
|
| Record UNII |
79F9I2R16M
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C921
Created by
admin on Mon Mar 31 18:21:21 GMT 2025 , Edited by admin on Mon Mar 31 18:21:21 GMT 2025
|
||
|
NCI_THESAURUS |
C1637
Created by
admin on Mon Mar 31 18:21:21 GMT 2025 , Edited by admin on Mon Mar 31 18:21:21 GMT 2025
|
||
|
WHO-VATC |
QM04AA02
Created by
admin on Mon Mar 31 18:21:21 GMT 2025 , Edited by admin on Mon Mar 31 18:21:21 GMT 2025
|
||
|
WHO-ATC |
M04AA02
Created by
admin on Mon Mar 31 18:21:21 GMT 2025 , Edited by admin on Mon Mar 31 18:21:21 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
TISOPURINE
Created by
admin on Mon Mar 31 18:21:21 GMT 2025 , Edited by admin on Mon Mar 31 18:21:21 GMT 2025
|
PRIMARY | |||
|
2682
Created by
admin on Mon Mar 31 18:21:21 GMT 2025 , Edited by admin on Mon Mar 31 18:21:21 GMT 2025
|
PRIMARY | |||
|
CHEMBL119423
Created by
admin on Mon Mar 31 18:21:21 GMT 2025 , Edited by admin on Mon Mar 31 18:21:21 GMT 2025
|
PRIMARY | |||
|
226-251-8
Created by
admin on Mon Mar 31 18:21:21 GMT 2025 , Edited by admin on Mon Mar 31 18:21:21 GMT 2025
|
PRIMARY | |||
|
100000082119
Created by
admin on Mon Mar 31 18:21:21 GMT 2025 , Edited by admin on Mon Mar 31 18:21:21 GMT 2025
|
PRIMARY | |||
|
135445058
Created by
admin on Mon Mar 31 18:21:21 GMT 2025 , Edited by admin on Mon Mar 31 18:21:21 GMT 2025
|
PRIMARY | |||
|
DB13807
Created by
admin on Mon Mar 31 18:21:21 GMT 2025 , Edited by admin on Mon Mar 31 18:21:21 GMT 2025
|
PRIMARY | |||
|
1392
Created by
admin on Mon Mar 31 18:21:21 GMT 2025 , Edited by admin on Mon Mar 31 18:21:21 GMT 2025
|
PRIMARY | |||
|
38136
Created by
admin on Mon Mar 31 18:21:21 GMT 2025 , Edited by admin on Mon Mar 31 18:21:21 GMT 2025
|
PRIMARY | RxNorm | ||
|
DTXSID90201488
Created by
admin on Mon Mar 31 18:21:21 GMT 2025 , Edited by admin on Mon Mar 31 18:21:21 GMT 2025
|
PRIMARY | |||
|
5334-23-6
Created by
admin on Mon Mar 31 18:21:21 GMT 2025 , Edited by admin on Mon Mar 31 18:21:21 GMT 2025
|
PRIMARY | |||
|
SUB11121MIG
Created by
admin on Mon Mar 31 18:21:21 GMT 2025 , Edited by admin on Mon Mar 31 18:21:21 GMT 2025
|
PRIMARY | |||
|
C80872
Created by
admin on Mon Mar 31 18:21:21 GMT 2025 , Edited by admin on Mon Mar 31 18:21:21 GMT 2025
|
PRIMARY | |||
|
C005832
Created by
admin on Mon Mar 31 18:21:21 GMT 2025 , Edited by admin on Mon Mar 31 18:21:21 GMT 2025
|
PRIMARY | |||
|
3842
Created by
admin on Mon Mar 31 18:21:21 GMT 2025 , Edited by admin on Mon Mar 31 18:21:21 GMT 2025
|
PRIMARY | |||
|
79F9I2R16M
Created by
admin on Mon Mar 31 18:21:21 GMT 2025 , Edited by admin on Mon Mar 31 18:21:21 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |